
Sign up to save your podcasts
Or
Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:
4.3
3131 ratings
Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:
1,264 Listeners
995 Listeners
509 Listeners
436 Listeners
2,289 Listeners
207 Listeners
87 Listeners
352 Listeners
188 Listeners
125 Listeners
63 Listeners
89 Listeners
120 Listeners
431 Listeners
33 Listeners
19 Listeners